Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Andrea Napolitano"'
Publikováno v:
Rare Tumors, Vol 16 (2024)
Externí odkaz:
https://doaj.org/article/75508af835d64629a3884bd7b4880467
Autor:
Bruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, Sarah Orlando, Davide Romandini, Juan Aguilar-Company, Isabel Ruiz-Camps, Claudia Valverde Morales, Simeon Eremiev-Eremiev, Carlo Tondini, Joan Brunet, Rossella Bertulli, Salvatore Provenzano, Mark Bower, Daniele Generali, Ramon Salazar, Anna Sureda, Aleix Prat, Michalarea Vasiliki, Mieke Van Hemelrijck, Ailsa Sita-Lumsden, Alexia Bertuzzi, Sabrina Rossi, Amanda Jackson, Federica Grosso, Alvin J. X. Lee, Cian Murphy, Katherine Belessiotis, Uma Mukherjee, Fanny Pommeret, Angela Loizidou, Gianluca Gaidano, Gino M. Dettorre, Salvatore Grisanti, Marco Tucci, Claudia A. M. Fulgenzi, Alessandra Gennari, Andrea Napolitano, David J. Pinato
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: To date, limited evidence exists on the impact of COVID-19 in patients with soft tissue sarcoma (STS), nor about the impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in this specific population. Me
Externí odkaz:
https://doaj.org/article/c4bf349d60eb4e95af965b6c9b1f4f0c
Autor:
Su Yin Lim, Laura Ferro-López, Elizabeth Barquin, Daniel Lindsay, Khin Thway, Myles J. Smith, Charlotte Benson, Robin L. Jones, Andrea Napolitano
Publikováno v:
Cancers, Vol 16, Iss 5, p 985 (2024)
Ripretinib, a novel tyrosine kinase inhibitor used in advanced gastrointestinal stromal tumors (GIST) resistant to standard therapies, was assessed in the United Kingdom (UK) within an Expanded Access Program (EAP). A retrospective review of patients
Externí odkaz:
https://doaj.org/article/ef2b7b79c89d4103b091e6aee3953071
Autor:
Valerio Donatiello, Aniello Alfieri, Andrea Napolitano, Vincenzo Maffei, Francesco Coppolino, Vincenzo Pota, Maria Beatrice Passavanti, Maria Caterina Pace, Pasquale Sansone
Publikováno v:
Journal of Anesthesia, Analgesia and Critical Care, Vol 2, Iss 1, Pp 1-6 (2022)
Abstract Background Dexmedetomidine is a highly selective alpha-2 receptor agonist without any effect on the GABA receptor. It provides an excellent sedative and analgesic profile with few side effects. We report our experience with dexmedetomidine u
Externí odkaz:
https://doaj.org/article/27c01d0c5beb401189dbc12a39ea90e5
Publikováno v:
Cancers, Vol 15, Iss 23, p 5619 (2023)
We appreciate the comment made by Chen et al. on our manuscript evaluating the systemic treatment options for gastrointestinal stromal tumours (GIST) [...]
Externí odkaz:
https://doaj.org/article/90d4d856d7b241838c72c612a839b499
Publikováno v:
Cancers, Vol 15, Iss 16, p 4081 (2023)
Gastrointestinal stromal tumours (GIST) are the most common mesenchymal tumours of the gastrointestinal tract. Surgical treatment is recommended for the majority of localised GIST, while systemic treatment is the cornerstone of management for metasta
Externí odkaz:
https://doaj.org/article/98178088e8ea41bf8d719ab83e365b66
Autor:
Andrea Napolitano, David S. Moura, Nadia Hindi, José L Mondaza-Hernandez, José A. Merino-Garcia, Rafael Ramos, Gian Paolo Dagrada, Silvia Stacchiotti, Francesco Graziano, Bruno Vincenzi, Javier Martin-Broto
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Solitary fibrous tumours (SFT) are soft tissue sarcomas molecularly defined by the presence of the NAB2::STAT6 intrachromosomal fusion gene. Recently, a prospective phase II trial evaluating the role of the antiangiogenic tyrosine kinase
Externí odkaz:
https://doaj.org/article/c5c4cc310572489188a815d2101aedcc
Autor:
Claudia Angela Maria Fulgenzi, Andrea Napolitano, Eliodoro Faiella, Laura Messina, Gennaro Castiello, Flavia Paternostro, Marianna Silletta, Francesco Pantano, Giuseppe Tonini, Daniele Santini, Bruno Vincenzi
Publikováno v:
Journal of Bone Oncology, Vol 34, Iss , Pp 100422- (2022)
Adjuvant treatment with Imatinib is the standard of care for high-risk resected GISTs. Imatinib is known to have an impact on bone mineral density in patients affected by chronic myeloid leukemia, however this effect has never been investigated in GI
Externí odkaz:
https://doaj.org/article/6b71d272acba46989af605eba6f809c1
Autor:
Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti, Fabrizio Citarella, Francesco Pantano, Emanuela Dell’Aquila, Cecilia Anesi, Nicola Silvestris, Antonella Argentiero, Antonio Solimando, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-13 (2020)
Abstract In a large number of cancer types, treatment selection depends on the presence of specific tumor biomarkers. Due to the dynamic nature of cancer, very often these predictive biomarkers are not uniformly present in all cancer cells. Tumor het
Externí odkaz:
https://doaj.org/article/df30fbd5545649af9ad98954967d60dd
Autor:
Marco Stellato, Daniele Santini, Elena Verzoni, Ugo De Giorgi, Francesco Pantano, Chiara Casadei, Giuseppe Fornarini, Marco Maruzzo, Andrea Sbrana, Giuseppe Di Lorenzo, Mariella Soraru, Emanuele Naglieri, Sebastiano Buti, Rocco De Vivo, Andrea Napolitano, Francesca Vignani, Claudia Mucciarini, Francesco Grillone, Giandomenico Roviello, Marilena Di Napoli, Giuseppe Procopio
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundImmune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) and radical nephrectomy (RN), with curative intent, in patients treated with IO
Externí odkaz:
https://doaj.org/article/8713aa9726304d1f9ceda49131f8daff